Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 2Breast 1

Conditions

Colorectal Neoplasms 29Rectal Neoplasms 8Colonic Neoplasms 7Carcinoma, Hepatocellular 7Cholangiocarcinoma 5Stomach Neoplasms 4Neoplasm Metastasis 4Neoplasms 3Biliary Tract Neoplasms 3Adenocarcinoma Of Esophagus 3Ovarian Neoplasms 2Gastrointestinal Neoplasms 2Gallbladder Neoplasms 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Solid Tumors 1Recurrence 1Pathologic Complete Response 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Lung Neoplasms 1Locally Advanced Rectal Cancer 1Locally Advanced Colorectal Carcinoma 1Liver Neoplasms 1Gastroesophageal Junction Adenocarcinoma 1Gastroesophageal Adenocarcinoma 1Gastro-enteropancreatic neuroendocrine tumor 1Endometrial Neoplasms 1Disease Progression 1Colorectal Cancer Metastatic 1

Interventions

pembrolizumab 243Carboplatin 211Pemetrexed 177Cisplatin 131Paclitaxel 113Nivolumab 101Docetaxel 87osimertinib 85durvalumab 78Specimen Handling 56atezolizumab 55Gemcitabine 52Drug Therapy 52Magnetic Resonance Spectroscopy 50Radiosurgery 48Radiotherapy 47Ipilimumab 41130-nm albumin-bound paclitaxel 39cemiplimab 38Bevacizumab 34Cetuximab 30tislelizumab 29amivantamab 22Taxes 22Platinum Compounds 20Blood Specimen Collection 20Immunotherapy 18Immune Checkpoint Inhibitors 18Radiation 17Erlotinib Hydrochloride 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Non-Small-Cell Lung × Folfox protocol × 1 year × Clear all
NCT06179160 2026-05-04

A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

Incyte Corporation

Phase 1 Recruiting
710 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT06625775 2026-04-13

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Phase 1 Recruiting
392 enrolled
BreastGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡